Drug Type Small molecule drug |
Synonyms 5-10 Methylenetetrahydrofolate, 5-FU biomodulator, CoFactor + [3] |
Target |
Action inhibitors |
Mechanism TYMS inhibitors(Thymidylate synthase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H23CaN7O6 |
InChIKeyXTTQVUYZSJQXLP-ZEDZUCNESA-N |
CAS Registry133978-75-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colonic Cancer | Phase 3 | United States | 01 May 2006 | |
| Colonic Cancer | Phase 3 | Montenegro | 01 May 2006 | |
| Metastatic Colorectal Carcinoma | Phase 3 | United States | 01 May 2006 | |
| Metastatic Colorectal Carcinoma | Phase 3 | Montenegro | 01 May 2006 | |
| Rectal Cancer | Phase 3 | United States | 01 May 2006 | |
| Rectal Cancer | Phase 3 | Montenegro | 01 May 2006 | |
| Advanced breast cancer | Phase 2 | Argentina | 01 Feb 2006 | |
| Advanced breast cancer | Phase 2 | Mexico | 01 Feb 2006 | |
| Advanced breast cancer | Phase 2 | Peru | 01 Feb 2006 | |
| Advanced breast cancer | Phase 2 | Russia | 01 Feb 2006 |





